The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs

Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action

(2013) Pau Celada et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efference Copy Failure during Smooth Pursuit Eye Movements in Schizophrenia

(2013) M. Spering et al.   JOURNAL OF NEUROSCIENCE

Altered Contextual Modulation of Primary Visual Cortex Responses in Schizophrenia

(2013) Kiley Seymour et al.   NEUROPSYCHOPHARMACOLOGY

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

(2012) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Activation of Thalamocortical Networks by the N-methyl-D-aspartate Receptor Antagonist Phencyclidine: Reversal by Clozapine

(2011) Noemí Santana et al.   BIOLOGICAL PSYCHIATRY

Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs

(2011) Miguel Fribourg et al.   CELL

Anticipating the future: Automatic prediction failures in schizophrenia

(2011) Judith M. Ford et al.   INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY

Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia

(2011) Maarten van den Buuse et al.   NEUROPHARMACOLOGY

Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT1A Receptor-Dependent Mechanism

(2011) Lucila Kargieman et al.   NEUROPSYCHOPHARMACOLOGY

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

(2011) José L. Moreno et al.   NEUROSCIENCE LETTERS

Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression

(2011) Lena Wischhof et al.   PSYCHOPHARMACOLOGY

Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors

(2010) L Lladó-Pelfort et al.   BRITISH JOURNAL OF PHARMACOLOGY

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Group II metabotropic glutamate receptors and schizophrenia

(2009) José L. Moreno et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions

(2008) Ai-Ming Yu   AAPS Journal

The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs

(2008) Pau Celada et al.   BIOLOGICAL PSYCHIATRY

Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors

(2008) P. Vazquez-Borsetti et al.   CEREBRAL CORTEX

Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

(2008) N. Santana et al.   CEREBRAL CORTEX

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors

(2008) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Serotonin research: contributions to understanding psychoses

(2008) M GEYER et al.   TRENDS IN PHARMACOLOGICAL SCIENCES